162 related articles for article (PubMed ID: 15980696)
1. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women.
Cohn JA; Hashemi FB; Camarca M; Kong F; Xu J; Beckner SK; Kovacs AA; Reichelderfer PS; Spear GT
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):340-6. PubMed ID: 15980696
[TBL] [Abstract][Full Text] [Related]
2. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
[TBL] [Abstract][Full Text] [Related]
3. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
[TBL] [Abstract][Full Text] [Related]
4. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.
Cohen CR; Lingappa JR; Baeten JM; Ngayo MO; Spiegel CA; Hong T; Donnell D; Celum C; Kapiga S; Delany S; Bukusi EA
PLoS Med; 2012; 9(6):e1001251. PubMed ID: 22745608
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
[TBL] [Abstract][Full Text] [Related]
6. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
7. Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.
Mitchell C; Balkus JE; Fredricks D; Liu C; McKernan-Mullin J; Frenkel LM; Mwachari C; Luque A; Cohn SE; Cohen CR; Coombs R; Hitti J
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):13-9. PubMed ID: 23020644
[TBL] [Abstract][Full Text] [Related]
8. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark.
Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM
BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142
[TBL] [Abstract][Full Text] [Related]
9. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.
Sha BE; Chen HY; Wang QJ; Zariffard MR; Cohen MH; Spear GT
J Clin Microbiol; 2005 Sep; 43(9):4607-12. PubMed ID: 16145114
[TBL] [Abstract][Full Text] [Related]
10. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1.
Olinger GG; Hashemi FB; Sha BE; Spear GT
AIDS; 1999 Oct; 13(14):1905-12. PubMed ID: 10513649
[TBL] [Abstract][Full Text] [Related]
11. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
[TBL] [Abstract][Full Text] [Related]
12. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions.
Delany S; Rosas R; Mlaba N; Clayton T; Akpomiemie G; LeGoff J; Capovilla A; Bélec L; Stevens W; Mayaud P
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):406-9. PubMed ID: 19186353
[TBL] [Abstract][Full Text] [Related]
16. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health.
Alcaide ML; Chisembele M; Malupande E; Arheart K; Fischl M; Jones DL
BMJ Open; 2015 Nov; 5(11):e009036. PubMed ID: 26553833
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
[TBL] [Abstract][Full Text] [Related]
20. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
